Controlled Inhibition of Apoptosis by Photoactivatable Caspase Inhibitors

Suravi Chakrabarty1, Steven H L Verhelst2

  • 1KU Leuven, Department of Cellular and Molecular Medicine, Laboratory of Chemical Biology, Herestraat 49 Box 802, 3000 Leuven, Belgium.

Cell Chemical Biology
|August 20, 2020
PubMed

Insights

Researchers developed photoactivatable caspase inhibitors to study apoptosis. These light-activated molecules precisely control apoptosis in live cells, offering new insights into cell death processes and related diseases.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Molecular Biology

Background:

  • Caspases are key regulators of apoptosis, essential for multicellular development and implicated in various diseases.
  • Studying the spatial and temporal dynamics of apoptosis is crucial for understanding biological processes and disease mechanisms.

Purpose of the Study:

  • To develop novel photoactivatable caspase inhibitors for spatiotemporal control of apoptosis.
  • To investigate the efficacy and applicability of these inhibitors in live-cell imaging and apoptosis studies.

Main Methods:

  • Design and synthesis of peptide-based caspase inhibitors featuring cysteine-reactive electrophiles.
  • Incorporation of a photoprotecting group (nitroindoline cage) on the critical aspartate residue for light-triggered activation.
  • Application of inhibitors in live cells to modulate anti-FAS-induced apoptosis upon light irradiation.

Main Results:

  • Developed photoactivatable caspase inhibitors with a stable nitroindoline cage, ensuring efficient light-induced activity.
  • Demonstrated that inhibitors prevent apoptosis in live cells exclusively after light exposure.
  • Validated the utility of these reagents for spatiotemporal studies of apoptosis.

Conclusions:

  • Photoactivatable caspase inhibitors provide precise spatial and temporal control over apoptosis.
  • These novel reagents are valuable tools for dissecting the complex dynamics of apoptosis in biological systems.
  • The developed inhibitors will advance the understanding of apoptosis in development and disease.

Related Concept Videos

Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside...
13.4K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
7.9K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
7.6K
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size...
13.4K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.4K
Phagocytosis of Apoptotic Cells01:17

Phagocytosis of Apoptotic Cells

Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or  immature dendritic cells. Non-professional phagocytes such as  epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes. 
Normal cells contain receptors that prevent them from being recognized...
4.6K